Protein cargo of Nef-containing exosomal extracellular vesicles may predict HIV-associated Neurocognitive Impairment status
Author:
Caobi Allen1, Werne Rachel1, Gomez Mario2, Andre Mickensone1, Lima-Hernandez Francisco2, Nair Madhavan1, Raymond Andrea Denise1, Thomas Charo1
Affiliation:
1. Herbert Wertheim College of Medicine, Florida International University 2. College of Arts, Sciences, and Education, Florida International University
Abstract
Abstract
Exosomal extracellular vesicles (xEVs) in plasma and cerebrospinal fluid (CSF) of aviremic people living with HIV/AIDS (PLWHA) contain the HIV Negative factor (Nef) protein. However, the role of xEVs and Nef-containing-xEVs(xEV-Nef) in HIV neuropathology is unknown. To determine whether the content of matched xEVs derived plasma or CSF correlated with the neurocognitive impairment (NCI) status of PLWHAs diagnosed with either asymptomatic neurocognitive impairment (ANI), mild neurocognitive disorder (MND), or HIV-associated dementia (HAD) a cross-sectional study was performed. The size and protein content of the xEVs characterized via dynamic light scattering (DLS) and LC-MS/MS, respectively. xEV size was not significantly different between ANI, MND, or HAD groups. CSF of PLWHAs with NCI contained significantly more xEVs than matched plasma. xEV-Nef CSF concentration was elevated in PLWHAs with NCI and correlated with CD4 T-cell count. Plasma-derived xEV protein profiles from PLWHAs with ANI or MND differed from PLWHAs without NCI. Over-representation analysis using Reactome and KEGG databases show proteins involved in pathways associated with heme scavenging, signaling(MAP kinase and integrin-alpha), Toll-like receptor regulation, clot formation, complement, and cytosolic calcium level were elevated in MND. Pathways upregulated within the ANI group involved high-density lipid (HDL) remodeling, post-translational protein phosphorylation, and platelet activation. Overall, the data shows that xEV protein profiles of ANI and MND differ, suggesting protein profiles of peripheral xEVs, xEV-Nef, and CD4 T-cell count may discern NCI status.
Publisher
Research Square Platform LLC
Reference53 articles.
1. Heaton, R.K., D.B. Clifford, D.R. Franklin, Jr., S.P. Woods, C. Ake, F. Vaida, R.J. Ellis, S.L. Letendre, T.D. Marcotte, J.H. Atkinson, M. Rivera-Mindt, O.R. Vigil, M.J. Taylor, A.C. Collier, C.M. Marra, B.B. Gelman, J.C. McArthur, S. Morgello, D.M. Simpson, J.A. McCutchan, I. Abramson, A. Gamst, C. Fennema-Notestine, T.L. Jernigan, J. Wong, I. Grant, and C. Group, HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 2010. 75(23): p. 2087-96. 2. The Prevalence of Frascati-Criteria-Based HIV-Associated Neurocognitive Disorder (HAND) in HIV-Infected Adults: A Systematic Review and Meta-Analysis;Wei J;Frontiers in Neurology,2020 3. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection;Janssen RS;Neurology,1991 4. Updated research nosology for HIV-associated neurocognitive disorders;Antinori A;Neurology,2007 5. Cerebrospinal fluid (CSF) CD8 + T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND);Schrier RD;PLoS One,2015
|
|